A multicenter randomised controlled trial of hydroxyurea (hydroxycarbamide) in very young children with sickle cell anaemia

BACKGROUND: Sickle cell anaemia (SCA) is associated with significant morbidity from acute complications and organ dysfunction beginning in the first year of life. In the first multicenter randomised double-blinded trial in very young children with SCA, the impact of hydroxyurea (hydroxycarbamide) th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wang, Winfred C, Ware, Russell E, Miller, Scott T, Iyer, Rathi V, Casella, James F, Minniti, Caterina P, Rana, Sohail, Thornburg, Courtney D, Rogers, Zora R, Kalpatthi, Ram V, Barredo, Julio C, Brown, R Clark, Sarnaik, Sharada A, Howard, Thomas H, Wynn, Lynn W, Kutlar, Abdullah, Armstrong, F Daniel, Files, Beatrice A, Goldsmith, Jonathan C, Waclawiw, Myron A, Huang, Xiangke, Thompson, Bruce W
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3133619/
https://ncbi.nlm.nih.gov/pubmed/21571150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(11)60355-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi